COMMUNIQUÉS West-GlobeNewswire

CYIOS Corp. Appoints John O’Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation
02/12/2025
MELBOURNE, Australia and PALM BEACH, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- CYIOS Corp. (OTC: CYIO), a diversified holding company focused on acquiring, building, and scaling high-growth businesses in the medical, [...]
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
02/12/2025
AUSTIN, Texas, Dec. 02, 2025 (GLOBE NEWSWIRE) -- BioMedWire : Chronic conditions and rare diseases in the aging population present an urgent and expanding challenge within the U.S. healthcare system, especially as more [...]
NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine
02/12/2025
FDA has determined that NRx’s Abbreviated New Drug Application (ANDA) is “substantially complete” and received for review. Assigned GDUFA goal date is July 29, 2026. NRx has applied to FDA for use of KETAFREE™ as a [...]
PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration (“FDA”)
02/12/2025
Company to Discuss Proposed Amendment to Phase 3 VERSATILE-003 Trial Enabling Potential Accelerated Approval Pathway PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS [...]
rYojbaba Announces the Launch of AI-Powered Worker Risk Intelligence Platform
02/12/2025
FUKUOKA, Japan, Dec. 02, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) ("rYojbaba" or the "Company"), a Japanese labor consulting and health services company, announced the launch of an AI-powered Worker [...]
PolarityBio Completes Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers
02/12/2025
PolarityBio thanks the clinical trial sites and, most importantly, the participants, for making this milestone in DFU biologic therapy development possible Final trial results anticipated in the first quarter of 2026 [...]
Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT
02/12/2025
sNDA for treatment of sBCC with Ameluz ® -PDT submitted to U.S. Food and Drug Administration (FDA) on November 28, 2025 First Phase 3 PDT study in patients with sBCC in the United States submitted to FDA Primary and key [...]
Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development
02/12/2025
Veteran gastroenterologist and clinical development leader with deep expertise driving global Phase 2/3 programs across immunology, neurology, and gastrointestinal disease Carlsbad, CA, Dec. 02, 2025 (GLOBE NEWSWIRE [...]
Cannabix Technologies Strengthens Presence in Maritime Market with Repeat BreathLogix Alcohol Screening Device Order
02/12/2025
VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is [...]
Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG
02/12/2025
Appointment reinforces clinical and translational depth as Ernexa advances its best-in-class iMSC cell therapy platform into first-in-human trials CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics [...]
YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection
02/12/2025
Taipei, Taiwan, Dec. 02, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Season Health and Albertsons Companies Launch Community Supports Service in California
02/12/2025
Eligible Medi-Cal members in Contra Costa County can now receive medically tailored grocery bundles from Safeway stores SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Season Health , a leading clinical nutrition [...]
Orbus Therapeutics Announces Publication of Phase 3 STELLAR Clinical Study Results Showing Clinically Meaningful Improvements in Rare Brain Tumor in Journal of Clinical Oncology (JCO)
02/12/2025
– Eflornithine and lomustine combination doubled progression free survival (PFS) and improved overall survival (OS) in patients with recurrent Grade 3 astrocytoma – PALO ALTO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- [...]
Citizen Health Joins Forces with UCB to Accelerate Drug Development across Epilepsy and Rare Diseases
02/12/2025
The multi-year partnership launches with focus on epilepsy, rare disease and AI SAN FRANCISCO and ATLANTA, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Citizen Health today announced a new strategic partnership with UCB, a global [...]
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer
02/12/2025
- FDA approval marks Alpha Tau’s fifth simultaneous active U.S. IDE as the Company expands Alpha DaRT’s reach into recurrent prostate cancer - JERUSALEM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ [...]
Reema Health Tackles Medicaid Challenges with $19M Series B from LRVHealth and Optum Ventures
02/12/2025
Engagement Model Blending Humans and Technology Drives 3X ROI to Medicaid MCOs MINNEAPOLIS, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Reema Health , the human powered and tech-enabled solution that engages hard-to-reach members [...]
Aeroflow Health Celebrates Giving Tuesday Through Donations to Western North Carolina Organizations
02/12/2025
Aeroflow donates several thousand dollars across seven local organizations based in its home state ASHEVILLE, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aeroflow Health , a pioneering healthcare company that leverages [...]
ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors
02/12/2025
– Dr. Tagliaferri is a proven executive recognized for advancing innovative therapies across immunology, oncology and other serious diseases – SAN DIEGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. ( [...]
BetaGlue Therapeutics Expands its Clinical Trial in Italy after obtaining from the Italian Ministry of Health Approval to conduct its clinical study in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)
02/12/2025
MILAN, Dec. 02, 2025 (GLOBE NEWSWIRE) -- BetaGlue ® Therapeutics (“BetaGlue” or the “Company”) a pioneering Italian clinical-stage oncology company developing an innovative radiotherapy solution for the targeted [...]

Pages